On Thursday, February 2, 2017, the inaugural symposium was held. The symposium featured distinguished scientists and profiled remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors. The following list highlights featured talks:
- “Advances in Personalized Cancer Immunotherapy”
Robert D. Schreiber, PhD
Andrew M. and Jane M. Bursky Distinguished Professor
Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs - “New Insights into Human Diseases Caused by Immune System Dysfunction”
Wayne M. Yokoyama, MD
Sam J. Levin and Audrey Lowe Levin Professor of Arthritis Research
Associate Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs - “Discoveries in Basic Biology of Infectious Diseases and Their Rapid Transition to Drug and Vaccine”
Michael S. Diamond, MD, PhD
Herbert S. Gasser Professor
Associate Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs - “Innovation, Crisis and the Role of Biotechnology”
Robert I. Tepper, MD
Partner and Co-Founder, Third Rock Ventures, LLC - “Building Better Medicines: The Role of the Biopharmaceutical Industry”
Roger M. Perlmutter, MD, PhD
Executive Vice President, Merck & Co.
President, Merck Research Laboratories
